View Older Stories

Feb 17, 2026 03:18PM Genmab initiates share buyback program worth up to 725 million DKK

Feb 17, 2026 04:23AM Jefferies Resumes Genmab A/S (GEN:DC) (GMAB) at Buy

Jan 28, 2026 06:42AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Jan 21, 2026 06:24AM Genmab reports $14.35 billion in DARZALEX sales for 2025

Jan 20, 2026 06:39AM Genmab A/S (GMAB) PT Lowered to $39 at H.C. Wainwright

Jan 16, 2026 01:52PM Genmab A/S (GMAB) resumes trading

Jan 16, 2026 12:59PM Genmab A/S (GMAB) halted, news pending

Jan 8, 2026 02:49AM Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,750 at UBS

Jan 7, 2026 09:02AM Genmab partners with Anthropic to deploy AI for drug development

Dec 29, 2025 08:11AM Genmab discontinues acasunlimab development to focus on late-stage programs

Dec 8, 2025 04:15AM Genmab A/S (GMAB) PT Raised to $38 at Leerink Partners

Dec 1, 2025 05:30PM This pharma stock has 3 'material catalysts' in 2026: BofA

Nov 18, 2025 11:30AM Genmab receives FDA approval for EPKINLY combination in follicular lymphoma

Nov 10, 2025 06:48AM Genmab A/S (GMAB) PT Raised to $41 at H.C. Wainwright

Nov 6, 2025 03:03PM Genmab A/S (GMAB) PT Lowered to $48 at Truist Securities

Oct 27, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Oct 21, 2025 08:13AM Genmab launches $97 per share tender offer for Merus

Oct 21, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Oct 14, 2025 06:23AM Genmab reports DARZALEX net sales of $3.67 billion in Q3 2025

Oct 13, 2025 04:48AM Genmab A/S (GMAB) PT Raised to $39 at Leerink Partners

Oct 6, 2025 08:44AM Genmab A/S (GMAB) PT Raised to $49 at Truist Post MRUS Acquisition

Oct 3, 2025 07:53AM Genmab A/S (GMAB) PT Raised to $49 at Truist Securities

Oct 3, 2025 06:41AM Genmab A/S (GMAB) PT Raised to $40 at H.C. Wainwright

Sep 30, 2025 08:25AM Truist Reiterates Buy Rating on Genmab A/S (GMAB) Following MRUS Bid

Sep 30, 2025 04:26AM Genmab A/S (GMAB) PT Raised to $32 at TD Cowen

Sep 29, 2025 01:09PM Genmab A/S (GMAB) PT Raised to $34 at Leerink Partners

Sep 23, 2025 07:45AM Guggenheim Upgrades Genmab A/S (GMAB) to Buy

Aug 15, 2025 06:51AM Genmab A/S (GMAB) PT Raised to $36 at H.C. Wainwright

Aug 12, 2025 02:38PM Genmab increases share capital by 4,563 shares from employee warrant exercise

Jul 8, 2025 08:35AM Genmab A/S (GMAB) PT Raised to $46; Truist: 'This Stock Deserves More Appreciation'

Jun 30, 2025 09:32AM Genmab A/S (GMAB) completes stock buyback plan

Jun 12, 2025 01:08PM Genmab A/S (GMAB) Announces Grant of Restricted Stock Units and Warrants to Employees

Jun 3, 2025 07:38AM Genmab A/S (GMAB) PT Raised to $32 at Leerink Partners

May 29, 2025 09:20AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,000 at RBC Capital on Fx Reset

May 23, 2025 11:10AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK17.50 at Deutsche Bank

May 14, 2025 07:51AM Genmab A/S (GMAB) PT Lowered to $35 at H.C. Wainwright

Apr 25, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Apr 15, 2025 06:23AM Genmab A/S (GMAB) Reports Q1 Net Sales of DARZALEX of $3.24B

Apr 1, 2025 03:20AM Bernstein SocGen Group Downgrades Genmab A/S (GEN:DC) (GMAB) to Underperform

Mar 25, 2025 05:34PM Genmab (GMAB) announces stock buyback program

Mar 24, 2025 08:38AM Genmab (GMAB) to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. (ABBV)

Mar 17, 2025 12:19PM Genmab A/S (GMAB) Reports Rina-S Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

Mar 11, 2025 09:16AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,300 at RBC Capital

Mar 11, 2025 06:04AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK1,900 at Deutsche Bank

Mar 11, 2025 01:11AM William Blair Upgrades Genmab A/S (GMAB) to Outperform

Mar 10, 2025 03:12PM Genmab A/S (GMAB) PT Lowered to $45 at Truist Securities

Mar 10, 2025 10:14AM Genmab A/S (GMAB): J&J will not exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBody-CD38

Feb 13, 2025 07:17AM Truist Securities Reiterates Buy Rating on Genmab A/S (GMAB)

Feb 13, 2025 06:20AM Leerink Partners Upgrades Genmab A/S (GMAB) to Outperform

Feb 11, 2025 02:52AM BNP Paribas Exane Upgrades Genmab A/S (GEN:DC) (GMAB) to Neutral

View Older Stories